Center-Authored Papers

Filters: Author is Montgomery, Bruce  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Z
Zhang X, Coleman I, Brown LG, True LD, Kollath L, Lucas JM, Lam H-M, Dumpit R, Corey E, Chéry L et al..  2015.  SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer.. Clinical cancer research : an official journal of the American Association for Cancer Research. Abstract
Zang T, Taplin M-E, Tamae D, Xie W, Mesaros C, Zhang Z, Bubley G, Montgomery B, Balk SP, Mostaghel EA et al..  2017.  Testicular vs adrenal sources of hydroxy-androgens in prostate cancer.. Endocrine-related cancer. 24(8):393-404. Abstract
W
Welty CJ, Coleman I, Coleman R, Lakely B, Xia J, Chen S, Gulati R, Larson SR, Lange PH, Montgomery B et al..  2013.  Single cell transcriptomic analysis of prostate cancer cells.. BMC molecular biology. 14:6. Abstract
T
Taplin M-E, McKay RR, Werner L, Mostaghel EA, Lis RT, Voznesensky O, Zhang Z, Marck B, Matsumoto AM, Domachevsky L et al..  2016.  A phase II trial of abiraterone combined with dutasteride for men with metastatic castration-resistant prostate cancer.. Clinical cancer research : an official journal of the American Association for Cancer Research. Abstract
Tamae D, Byrns M, Marck B, Mostaghel EA, Nelson PS, Lange P, Lin D, Taplin M-E, Balk S, Ellis W et al..  2013.  Development, validation and application of a stable isotope dilution liquid chromatography electrospray ionization/selected reaction monitoring/mass spectrometry (SID-LC/ESI/SRM/MS) method for quantification of keto-androgens in human serum.. The Journal of steroid biochemistry and molecular biology. 138C:281-289. Abstract
Tamae D, Mostaghel E, Montgomery B, Nelson PS, Balk SP, Kantoff PW, Taplin M-E, Penning TM.  2015.  The DHEA-sulfate depot following P450c17 inhibition supports the case for AKR1C3 inhibition in high risk localized and advanced castration resistant prostate cancer.. Chemico-biological interactions. 234:332-8. Abstract
S
Schweizer MT, Cheng HH, Tretiakova MS, Vakar-Lopez F, Klemfuss N, Konnick EQ, Mostaghel EA, Nelson PS, Yu EY, Montgomery B et al..  2016.  Mismatch repair deficiency may be common in ductal adenocarcinoma of the prostate.. Oncotarget. Abstract
R
Roudier MP, Winters BR, Coleman I, Lam H-M, Zhang X, Coleman R, Chéry L, True LD, Higano CS, Montgomery B et al..  2016.  Characterizing the molecular features of ERG-positive tumors in primary and castration resistant prostate cancer.. The Prostate. 76(9):810-22. Abstract
Robinson D, Van Allen EM, Wu Y-M, Schultz N, Lonigro RJ, Mosquera J-M, Montgomery B, Taplin M-E, Pritchard CC, Attard G et al..  2015.  Integrative clinical genomics of advanced prostate cancer.. Cell. 161(5):1215-28. Abstract
P
Pritchard CC, Mateo J, Walsh MF, DeSarkar N, Abida W, Beltran H, Garofalo A, Gulati R, Carreira S, Eeles R et al..  2016.  Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.. The New England journal of medicine. 375(5):443-453. Abstract
M
Murphy C, True L, Vakar-Lopez F, Xia J, Gulati R, Montgomery B, Tretiakova M.  2016.  A novel system for estimating residual disease and pathologic response to neoadjuvant treatment of prostate cancer.. The Prostate. Abstract
Mostaghel EA, Plymate SR, Montgomery B.  2014.  Molecular pathways: targeting resistance in the androgen receptor for therapeutic benefit.. Clinical cancer research : an official journal of the American Association for Cancer Research. 20(4):791-8. Abstract
Mostaghel EA, Wright JL, Montgomery B, Stanford JL.  2011.  SLCO Transport Genes in Prostate Cancer--Response.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 20(10):2326-7.
Mostaghel EA, Nelson PS, Lange P, Lin DW, Taplin ME, Balk S, Ellis W, Kantoff P, Marck B, Tamae D et al..  2014.  Targeted androgen pathway suppression in localized prostate cancer: a pilot study.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(3):229-37. Abstract
Mostaghel EA, Montgomery B, Nelson PS.  2009.  Castration-resistant prostate cancer: targeting androgen metabolic pathways in recurrent disease.. Urologic oncology. 27(3):251-7. Abstract
Mostaghel EA, Cho E, Zhang A, Alyamani M, Kaipainen A, Green S, Marck B, Sharifi N, Wright JL, Gulati R et al..  2017.  Association of Tissue Abiraterone Levels and SLCO Genotype with Intraprostatic Steroids and Pathologic Response in Men with High-Risk Localized Prostate Cancer.. Clinical cancer research : an official journal of the American Association for Cancer Research. Abstract
Montgomery B, Nelson PS, Vessella R, Kalhorn T, Hess D, Corey E.  2010.  Estradiol suppresses tissue androgens and prostate cancer growth in castration resistant prostate cancer.. BMC cancer. 10:244. Abstract
Montgomery B, Tretiakova MS, Joshua AM, Gleave ME, Fleshner N, Bubley GJ, Mostaghel EA, Chi KN, Lin D, Sanda M et al..  2016.  Neoadjuvant Enzalutamide Prior to Prostatectomy.. Clinical cancer research : an official journal of the American Association for Cancer Research. Abstract
Montgomery B, Cheng HH, Drechsler J, Mostaghel EA.  2014.  Glucocorticoids and prostate cancer treatment: friend or foe? Asian journal of andrology. Abstract
Meng J, Mostaghel EA, Vakar-Lopez F, Montgomery B, True L, Nelson PS.  2011.  Testosterone regulates tight junction proteins and influences prostatic autoimmune responses.. Hormones & cancer. 2(3):145-56. Abstract
L
Larson SR, Zhang X, Dumpit R, Coleman I, Lakely B, Roudier M, Higano CS, True LD, Lange PH, Montgomery B et al..  2013.  Characterization of osteoblastic and osteolytic proteins in prostate cancer bone metastases.. The Prostate. 73(9):932-40. Abstract
K
Kumar A, Coleman I, Morrissey C, Zhang X, True LD, Gulati R, Etzioni R, Bolouri H, Montgomery B, White T et al..  2016.  Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer.. Nature medicine. Abstract
H
Harris WP, Mostaghel EA, Nelson PS, Montgomery B.  2009.  Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion.. Nature clinical practice. Urology. 6(2):76-85. Abstract
Haider M, Zhang X, Coleman I, Ericson N, True LD, Lam H-M, Brown LG, Ketchanji M, Nghiem B, Lakely B et al..  2015.  Epithelial mesenchymal-like transition occurs in a subset of cells in castration resistant prostate cancer bone metastases.. Clinical & experimental metastasis. Abstract
D
Dean JP, Sprenger CC, Wan J, Haugk K, Ellis WJ, Lin DW, Corman JM, Dalkin BL, Mostaghel E, Nelson PS et al..  2013.  Response of the Insulin-Like Growth Factor (IGF) System to IGF-IR Inhibition and Androgen Deprivation in a Neoadjuvant Prostate Cancer Trial: Effects of Obesity and Androgen Deprivation.. The Journal of clinical endocrinology and metabolism. 98(5):E820-8. Abstract